CStone Pharmaceuticals
HKEX:2616

Watchlist Manager
CStone Pharmaceuticals Logo
CStone Pharmaceuticals
HKEX:2616
Watchlist
Price: 1.81 HKD -0.55% Market Closed
Market Cap: 2.3B HKD
Have any thoughts about
CStone Pharmaceuticals?
Write Note

Wall Street
Price Targets

Price Targets Summary
CStone Pharmaceuticals

Wall Street analysts forecast CStone Pharmaceuticals stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CStone Pharmaceuticals is 2.56 HKD with a low forecast of 2.54 HKD and a high forecast of 2.64 HKD.

Lowest
Price Target
2.54 HKD
40% Upside
Average
Price Target
2.56 HKD
41% Upside
Highest
Price Target
2.64 HKD
46% Upside
CStone Pharmaceuticals Competitors:
Price Targets
EXAI
Exscientia PLC
1% Downside
ELDN
Eledon Pharmaceuticals Inc
249% Upside
DVYSR
Devyser Diagnostics AB
11% Upside
MAAT
Maat Pharma SA
99% Upside
2696
Shanghai Henlius Biotech Inc
13% Upside
2256
Abbisko Cayman Ltd
161% Upside
ORGO
Organogenesis Holdings Inc
19% Upside
PROB
Probi AB
15% Downside

Revenue
Forecast

Revenue Estimate
CStone Pharmaceuticals

The compound annual growth rate of CStone Pharmaceuticals's revenue for the next 3 years is 26%.

N/A
Past Growth
26%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
CStone Pharmaceuticals

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
CStone Pharmaceuticals

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CStone Pharmaceuticals's stock price target?
Price Target
2.56 HKD

According to Wall Street analysts, the average 1-year price target for CStone Pharmaceuticals is 2.56 HKD with a low forecast of 2.54 HKD and a high forecast of 2.64 HKD.

What is CStone Pharmaceuticals's Revenue forecast?
Projected CAGR
26%

The compound annual growth rate of CStone Pharmaceuticals's revenue for the next 3 years is 26%.

Back to Top